NightHawk Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NightHawk Biosciences generated cash of -$5,700,364, which is more than the previous year. Cash used in financing activities reached the amount of -$4,906,941 last year. Net change in cash is therefore $380,675.
Cash Flow
| 2013 | -6.38M | -17.39M | 28.34M |
|---|---|---|---|
| 2014 | -9.82M | 5.96M | 3.01M |
| 2015 | -17.44M | 3.75M | 15.01M |
| 2016 | -13.52M | 6.61M | 9.80M |
| 2017 | -6.30M | -530.18K | 8.76M |
| 2018 | -21.71M | -6.16M | 40.11M |
| 2019 | -12.83M | -293.99K | 19.05K |
| 2020 | -22.02M | -95.41M | 119.32M |
| 2021 | -38.12M | 9.77M | 25.49M |
| 2022 | -5.70M | 10.99M | -4.90M |
NHWK Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 8.05M | 10.93M | 9.03M | 22.15M | 9.76M | 7.84M | 4.93M | 3.71M | 4.56M | 5.03K |
Operating activities | ||||||||||
Net income | -43.86M | -35.40M | -26.38M | -20.38M | -16.59M | -12.40M | -12.97M | -21.12M | -12.24M | -6.60M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.14M | 607.66K | 333.15K | 232.50K | 237.31K | 134.08K | 132.07K | 116K | 66.89K | 6.34K |
Stock-based compensation expense | 4.08M | 6.16M | 6.37M | 3.26M | 788.65K | 689.13K | 582.63K | 1.57M | 1.06M | 571.92K |
| Deferred income tax benefit | 4.08M | 6.16M | 6.37M | 3.26M | 788.65K | 689.13K | 582.63K | 1.57M | 1.06M | 571.92K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -15.96K | 110.11K | -140.55K | -6.47K | -14.09K | 67.76K | -82.44K | -9K | -24K | 0 |
Inventories | 5.84M | -13.70M | -1.33M | -298.04K | 176.80K | -719.14K | -54.38K | 0 | 0 | 0 |
Accounts payable | 3.29M | -126.93K | -452.77K | 529.26K | -55.82K | -175.90K | -1.69M | 642K | 715.50K | 146.44K |
Cash generated by operating activities | -5.70M | -38.12M | -22.02M | -12.83M | -21.71M | -6.30M | -13.52M | -17.44M | -9.82M | -6.38M |
Investing activities | ||||||||||
Purchases Of Investments | -2.45M | -66.96M | -105.92M | -138.43K | -5.57M | 0 | 0 | -11.09M | -12.19M | -17.34M |
Investments In Property Plant And Equipment | -20.11M | -1.90M | -337.97K | -265.18K | -593.57K | -61.38K | -45.93K | -116K | -458.67K | -49.31K |
Acquisitions Net | -20.06M | -11.67M | 2.16K | 109.63K | 0 | -468.80K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 10.99M | 9.77M | -95.41M | -293.99K | -6.16M | -530.18K | 6.61M | 3.75M | 5.96M | -17.39M |
Financing activities | ||||||||||
Common Stock Issued | 59.69K | 26.30M | 123.97M | 18.89K | 38.41M | 9.09M | 13.36M | 11.4M | 0 | 25.11M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -97.05K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -183.01K | -817.19K | 0 | 0 | 0 | -6.94M | 0 | 0 | -1.12M |
Cash used in financing activities | -4.90M | 25.49M | 119.32M | 19.05K | 40.11M | 8.76M | 9.80M | 15.01M | 3.01M | 28.34M |
Net Change In Cash | 380.67K | -2.87M | 1.89M | -13.11M | 12.38M | 1.92M | 2.90M | 1.22M | -852.68K | 4.56M |
Cash at end of period | 8.43M | 8.05M | 10.93M | 9.03M | 22.15M | 9.76M | 7.84M | 4.94M | 3.71M | 4.56M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |